ChinaBio Today -- JOINN Laboratories has a very specific vision of the future for CROs in China. “We expect a huge increase in demand for CRO services,” said John Gong, PhD, VP and CTO of JOINN in an exclusive interview with ChinaBio® Today. “In the near future, pharma will outsource 75% of its pre-clinical work, up from a level of about 25% today.”
